The Valley Desk

NCT06097299 · Interventional trial

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Overall registry status Completed

Phase 2

Conditions Respiratory Syncytial Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov